#Neurological Disorders
4 articles with this tag
Funding Round
Circular Genomics Secures $15 Million Series A for Alzheimer's Blood Test
4 months ago
Funding Round
NRG Therapeutics Secures £50M Series B for ALS, Parkinson's Drugs
NRG Therapeutics secured £50 million in Series B funding, led by SV Health Investors’ Dementia Discovery Fund. This investment will advance mitochondrial-targeting treatments for neurodegenerative diseases. The company aims to transition its pipeline, including lead candidate NRG5051 for ALS and Parkinson's, into...
6 months ago
Funding Round
Neuralink Secures Massive $650M Series E Funding
10 months ago
Press Release
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
10 months ago